Life Biosciences

Description

Develops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial focused on optic neuropathies.

Related

• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Intellia Therapeutics ($NTLA)Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited…
• Merck Cambridge Discovery ($MRK)Develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases including cancer, infectious,…
• Verve TherapeuticsSingle-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
• Cabaletta Bio ($CABA)Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• Kyverna Therapeutics ($KYTX)Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and…
• HAYA TherapeuticsBuilds RNA-guided therapies that reprogram disease-driving cell states; used to reverse cell states and restore health in therapeutic…
• ONCOMATRYX BIOPHARMA SLOncomatryx develops biotechnology programs focused on modulating the tumor microenvironment.
• NewLimitDevelops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related…